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We investigated the feasibility of using vaccinia virus (VAC) recombinants containing large multigene fragments of orf
virus DNA to identify protective antigens of orf virus (OV). Sixteen OV strain NZ2 DNA fragments with an average size of
11.4 kb were recombined into VAC strain Lister. Each fragment was mapped relative to OV restriction endonuclease maps
but was otherwise uncharacterized. Together the recombinants represent 95% of the OV genome in an overlapping manner.
Immunofluorescence showed all 16 constructs expressed products recognized by OV antiserum and radioimmune precipita-
tion with the same antiserum allowed the localization of the major antigens of OV to specific recombinants. These data
indicated the approximate genomic locations of the genes encoding the OV major antigens and showed that their expression
was authentic rather than resulting from read through from VAC sequences adjacent to the site of recombination. Vaccination
of OV-naive sheep with the recombinant library provided protection against a subsequent challenge with virulent OV. These
data confirm the feasibility of the proposed strategy. q 1997 Academic Press
INTRODUCTION be in part because it is likely that cell-mediated immune
responses play a major role in protection against poxvi-
Orf virus (OV) is the type species of the Parapoxvirus ruses. Antibodies able to neutralize poxviruses have
genus in the family Poxviridae (Robinson and Lyttle, been reported and antibodies directed against antigens
1992). It causes a contagious pustular dermatitis of such as those derived from the extracellular enveloped
sheep and goats that is transmissible to humans. The form of VAC may restrict the spread of infection and
139-kb genome of OV has been mapped with restriction may assist in limiting reinfection but antibody-mediated
endonucleases and all but the terminal hairpin loop mechanisms are generally insufficient to protect against
structures have been cloned (Mercer et al., 1987; Rob- infection by a poxvirus (reviewed in Buller and Palumbo,
inson et al., 1982). DNA sequence data of limited regions 1991). In the case of poxviruses such as OV for which
of the genome have been published (Fleming et al., 1993;
there is no evidence of systemic spread during infection,
Fraser et al., 1990; Mercer et al., 1989, 1996, 1995; Naase
it is possible that only the cell-mediated responses are
et al., 1991; Sullivan et al., 1995a, 1995b, 1994), but in
relevant and that antibodies have no significant role in
general little is known about OV at the molecular level.
resolving or restricting the infection (reviewed in Rob-
This is in contrast to vaccinia virus (VAC), the type spe-
inson and Lyttle, 1992). Identification of viral proteinscies of the Poxviridae, for which the complete DNA se-
which stimulate these cell-mediated responses will re-quence has been published and numerous genes have
quire the endogenous production of the relevant anti-been assigned functions (Goebel et al., 1990).
gen(s). This could be achieved by using a vector ableVAC played a crucial role in the global eradication
to express candidate genes in the appropriate animalof smallpox. Despite this distinguished history and our
species. In recent years VAC has been widely used forextensive knowledge of VAC, the viral proteins that are
the expression of foreign genes (Moss, 1991; Tartaglia,the targets of the protective immune response have not
Pincus, and Paoletti, 1990). In nearly all cases the se-been clearly identified for VAC or any poxvirus. This may
quence of the foreign gene has been determined and
the gene placed so as to be transcribed from a strong
VAC promoter. The resulting cassette is then recombined1 To whom correspondence and reprint requests should be
addressed. Fax: /64 3 4797744. E-mail: andy.mercer@stonebow. into the VAC genome.
otago.ac.nz. We have mapped the transcriptional start points of a
2 Present address: The Centre for HIV Research, University of Edin- limited number of OV genes and identified likely promoterburgh, Edinburgh, U.K.
regions 5* of these points (Fleming et al., 1993, 1991,3 Present address: CSIRO Division of Wildlife and Ecology, P.O. Box
84, Lyneham, ACT 2602, Australia. 1992; Sullivan et al., 1995a, 1995b, 1994). We have also,
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for some of these OV early genes demonstrated that their 0.5% polyethylene glycol 6000 (PEG) and 0.6 M NaCl.
After 2 hr on ice, the mixture was centrifuged at 9000 gpromoters are recognized by the VAC transcriptional ma-
chinery resulting in faithful transcription of OV early for 5 min and the pellet washed with 5% PEG–0.6 M
NaCl. The pelleted DNA was then resuspended in 10genes from their own promoters both when these genes
are carried by VAC recombinants (Fleming et al., 1992) mM Tris, 1 mM EDTA, pH 8 (TE), extracted with phenol,
and then a 1 to 1 mix of phenol and chloroform, beforeand when they are provided as templates in an in vitro
assay with transcriptionally active extracts of VAC (Vos being precipitated with ethanol, and resuspended in TE.
Aliquots of this DNA were ligated to BamHI-digested, calfet al., 1992). This faithful cross-generic transcription sug-
gests that OV genes could be expressed in VAC recombi- alkaline phosphatase-treated pVU77 (see below).
nants without the need to fuse each OV open reading
Construction of recombinant vaccinia virusesframe to a VAC promoter. Instead large fragments of
OV DNA, carrying multiple, undefined genes could be
Insertion vector plasmids containing OV DNA frag-
recombined into VAC and the recombinants then
ments were used to produce VAC recombinants by ho-
screened for the ability to generate an immune response
mologous recombination at the thymidine kinase (TK)
able to protect against a subsequent challenge with OV.
locus (Mackett et al., 1985). The vectors used in the con-
Further analyses of subclones derived from the relevant
struction of the library were pUV1 (Falkner et al., 1987),
recombinants would identify the OV genes encoding
pGS20 (Mackett et al., 1984), and pVU77, a derivative of
dominant protective antigens. This approach would cir-
pGS20 made in this laboratory. Digestion of pGS20 with
cumvent the necessity to first identify and then screen
EcoRI removed a 0.3-kb fragment carrying the P7.5 pro-
individual OV genes. We have previously shown that in-
moter element and this was replaced with a 42-bp EcoRI
fection of sheep with VAC does not provide cross-protec-
fragment derived from the cloning cassette of pUC7. Fur-
tion against OV (Mercer et al., 1994; Robinson and Mer-
ther digestion with BamHI followed by religation reduced
cer, 1988).
the cloning region to a single BamHI site closely flanked
We report here an analysis of the feasibility of the
by EcoRI sites (GAATTCCCCGGATCCGGGGAATTC).
proposed strategy. An OV DNA library whose 16 mem-
This construct was called pVU77.
bers cover 95% of the OV genome in an overlapping
Plasmid DNA was introduced into VAC-infected
manner was constructed in VAC. Expression of OV genes
TK143B cells by precipitation with calcium phosphate
was detected and vaccination of sheep with the recombi-
or the use of a liposome preparation (Lipofectin, BRL).
nant library provided protection against challenge with
Recombinants were selected by plaque assay in the
virulent OV.
presence of 5-bromodeoxy-uridine (BDUR) and, in the
case of vector pUV1, stained with 5-bromo-4-chloro-3in-
MATERIALS AND METHODS dolyl-D-galactopyranoside. In the case of vectors pVU77
and pGS20, BDUR-resistant plaques were individuallyCells and viruses
passaged in 24-well tissue culture plates and recombi-
The OV strain used was NZ2 (Robinson et al., 1982) nants detected by dot-blot hybridization of aliquots of
and the VAC strain, Lister (Robinson and Mercer, 1988). the lysates with OV-specific DNA probes. Four cycles of
VAC recombinants containing fragments of OV DNA were plaque purification were carried out before virus stocks
given the prefix VVOV and a clone number (see below). were prepared. The identity of each recombinant was
Primary bovine testis cells were grown in supplemented confirmed by restriction endonuclease and DNA/DNA hy-
Eagles minimal essential medium (MEM) containing 10% bridization analyses of purified viral DNA (Esposito et al.,
fetal bovine serum (FBS) (Balassu and Robinson, 1987). 1981). Each recombinant was given the prefix VVOV and
TK143B cells were grown in Eagles modified autoclav- the same number as that of the plasmid used in its con-
able MEM plus 10% FBS. African green monkey kidney struction.
fibroblasts, CV-1 cells, were grown in Eagle’s MEM plus
10% FBS. Immunofluorescence
CV-1 cells were grown to confluence on coverslips.DNA manipulations
After washing, the cells were inoculated at a multiplicity
of infection (m.o.i.) of 0.01 with one of the 16 VVOV recom-In vitro DNA manipulations were performed according
to standard methods (Sambrook et al., 1989) or have binants under test. Other cells were inoculated with VAC
or a VAC recombinant (VVBGAL) containing the Esche-been described previously (Fraser et al., 1990; Mercer et
al., 1987). To produce a library of large and overlapping richia coli b-galactosidase gene under the direction of
the VAC P11 promoter (Falkner et al., 1987) as negativefragments of OV DNA, 4.5 mg of OV DNA was partially
digested with Sau3AI. Small DNA fragments were re- controls or OV as positive controls. Eighteen hours later
the coverslips were washed in PBS, air-dried, fixed inmoved from the digest by selective precipitation with
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TABLE 1cold acetone for 10 min, and stained for presence of OV
protein in an indirect immunofluorescence test. The first OV Insertion Library
stage serum was a 1/200 dilution of a sheep hyperim-
Number Vector Origin Coordinatesmune serum preadsorbed with VAC-infected CV-1 cell
lysate (McKeever et al., 1987) and the 2nd stage serum
pVU216 pUV1 KpnI G 1.3–10.4a 1/80 dilution of donkey anti-sheep IgG conjugated to
pVU80 pGS20 EcoRI BamHI B/HindIII C* 8.2–16.8
fluorescein isothiocyanate (Scottish Antibody Production pVU215 pUV1 KpnI F 10.4–20.3
Unit, Carluke). The intensity of fluorescence was judged pVU213 pUV1 HindIII A/KpnI MSO* 16.8–26.4
pVU97 pVU77 Sau3A 24.3–34.0relative to cells infected with OV and the results ex-
pVU96 pVU77 Sau3A 30.3–46.3pressed on a scale of / to /////.
pVU212 pUV1 KpnI D 41.9–53.1
pVU245 pUV1 Sau3A 48.3–66.4
pVU247 pUV1 Sau3A 56.3–68.8Immune precipitation
pVU86 pVU77 Sau3A 64.6–81.4
pVU285 pUV1 Sau3A 75.4–89.4Bovine testis cells were infected with virus at an m.o.i.
pVU243 pUV1 BamHI A/HindIII A 82.9–93.5
of 10. At 6 hr postinfection for VAC and VVOV and at pVU283 pUV1 Sau3A 89.4–104.6
19 hr postinfection for OV, the medium was changed to pVU330 pUV1 BglII D 103.3–108.6
pVU85 pVU77 EcoRI D 107.4–118.1methionine-free RPMI-1640 medium (Sigma) containing
pVU82 pVU77 Sau3A 123.1–137.6[35S]methionine (25 mCi per 4 1 105 cells). After 3 hr the
cells were washed twice with PBS and lysed in 175 ml
Note. Members of the library are recombinant plasmids made in the
RIPA buffer (0.05 M Tris, pH 7.5, 0.15 M NaCl, 1% Nonidet vectors pUV1, pVU77, or pGS20. Each OV DNA fragment was derived
P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mg per ml by either partial digestion with Sau3AI or was a defined restriction
fragment described in published maps of OV (Mercer et al., 1987).aprotinin, 100 mg per ml phenylmethylsulfonyl fluoride)
BamHI A/HindIII A and BamHI B/HindIII C represent the region ofbefore centrifugation in a microfuge at 47. Cell extract
overlap between each pair of fragments. Those fragments marked with(150 ml) was mixed with 2 ml of the same preadsorbed
an asterisk were cloned into EcoRI-digested vectors after the fragment
hyperimmune anti-OV sheep serum that had been used had been made blunt with T4 DNA polymerase and ligated to EcoRI
for the immunofluorescence studies and incubated at 47 linkers. The location of each OV DNA fragment on the OV restriction
map is given in kb from the left end of the genome.overnight. Immune complexes were reacted with protein
G-agarose (Sigma) at 47 for 1.5 hr, collected by centrifu-
gation, and washed three times with RIPA buffer. The
RESULTSprecipitated proteins were resuspended in gel-loading
buffer, boiled for 2 min, electrophoresed on a 12.5% SDS –
OV DNA was partially digested with Sau3AI and size-polyacrylamide gel, and visualized by autoradiography.
selected by precipitation with 5% PEG–0.6 M NaCl. Agar-
ose gel electrophoresis of a portion of this DNA revealed
Immunization and challenge that it ranged in size from greater than 20 kb to no smaller
than 4 kb. It was ligated to the insertion vector, pVU77,
Four hysterectomy-derived, colostrum-deprived gnoto- and then transformed into E. coli HB101. Recombinant
biotic lambs obtained according to published methods plasmids were recovered either by direct screening of
(Hart et al., 1971) were reared in pairs in sterile plastic transformants or after colony hybridization with an OV
isolators. When 24 hr old, two lambs were each vacci- DNA probe. A total of 80 recombinant plasmids were
nated with 16 VVOV recombinants applied at separate analyzed. These contained OV DNA fragments ranging
sites on the hairless skin of the inguinal and axillary in size from 4 to 18 kb with an average size of 12 kb.
region. Vaccination was done by lightly scarifying a dis- Restriction endonuclease digestion and hybridization
crete 1-cm2 area with a 16-g needle and applying approx- with mapped fragments of OV DNA provided information
imately 0.1 ml of VVOV recombinant with an infectivity on the genomic location of inserts carried by the recombi-
titer of approximately 1 1 106 TCID50 per milliliter. The nant plasmids. Eight of the plasmids were included in
two control lambs were vaccinated in the same way ex- the library (Table 1). The OV DNA contained in these
cept that each of the 16 scarified sites received 0.1 ml eight plasmids totalled 116.4 kb in length (average 14.6
of VVBGAL with an infectivity titer of 1 1 106 TCID50 per kb) and when the overlap between clones was allowed
milliliter. At 21 days old all four lambs were challenged for they covered 92.4 kb of the 139 kb genome. Advan-
with virulent OV and the resulting lesions scored on a tage was taken of the EcoRI sites flanking the point of
daily basis for 3 weeks as previously described (Net- insertion into pVU77 to subclone the inserts of four plas-
tleton et al., 1996). All lambs were bled at weekly intervals mids to pUV1 (pVU245, 247, 86, and 285). Gaps in the
and serum antibody levels to OV were measured using collection were filled by cloning mapped restriction frag-
ments into the insertion vectors pVU77, pGS20, or pUV1.an ELISA assay (Nettleton et al., 1996).
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Cells infected with OV were rounded and fluorescence
was distributed widely in the cytoplasm (Fig. 2a). In cells
containing VVOV recombinants fluorescence was more
commonly patchy and restricted to discrete sites (Fig.
2b). At higher magnification, recombinants generally
gave a patchy granular distribution of fluorescence (Fig.
2c) although areas where the whole cytoplasm was fluo-FIG. 1. Genomic locations of the DNA fragments constituting the
rescing were also obvious in those recombinants givinginsertion library. The position of each DNA fragment is shown against
the KpnI map of OV strain NZ2. Note that KpnI map has been inverted the strongest fluorescence (Fig. 2d).
from that published previously (Mercer et al., 1987). To further examine the expression of OV proteins by
the library, the recombinants were tested by immune
precipitation with antiserum raised against OV. Recombi-The resulting library of 16 clones is shown in Fig. 1 and
nant-infected cells were pulse labeled with [S35]-details of each clone are provided in Table 1. The average
methionine at a late stage of infection and the labeledoverlap between clones is 4.3 kb with the smallest being
proteins were precipitated with hyperimmune anti-OV1.2 kb. The only regions of the OV genome not included in
sheep antiserum in conjunction with protein G agarose.the library are sections of approximately 1.3 kb at each
Precipitated proteins were electrophoresed on a SDS–terminus and a 5-kb gap between clones pVU82 and
polyacrylamide gel in parallel with proteins similarly pre-pVU85. Repeated attempts to construct a clone spanning
cipitated from OV-infected cells labeled at an equivalentthis latter region have been unsuccessful.
time postinfection. The results are shown in Fig. 3. EightEach plasmid of the library was used to make a VAC
strong bands were seen in the sample derived from OV-recombinant. Plasmid DNA was introduced into VAC-in-
infected cells (lane 3). The molecular weights of thesefected cells and TK-deficient recombinants were se-
bands were calculated as 108, 85, 72, 69, 47, 43, 28, andlected from the progeny by growth in the presence of
27 kDa. Bands comigrating with five of these bands wereBDUR. HindIII digests of DNA purified from each recom-
also seen in samples derived from members of the re-binant gave the predicted fragmentation pattern. The
combinant library, suggesting that the 108-kDa OV anti-identity of each recombinant was further confirmed by
gen is encoded by VVOV283 and VVOV243, the 85- andhybridization with radiolabeled OV DNA (not shown). The
72-kDa OV antigens are encoded by VVOV285, the 43-largest recombinant genome is that of VVOV245 in which
kDa OV antigen is encoded by VVOV245, and the 27-kDaa total of 22.3 kb has been recombined into VAC (18.1
antigen is encoded by VVOV283. Additional faint bandskb of OV DNA plus 4.2 kb derived from pUV1).
of 38 and 34 kDa were seen in the sample derived fromIn order to test that the recombinants were able to
OV-infected cells and these two antigens appear to beexpress at least some of the OV genes they carried, cells
encoded by VVOV96 and VVOV283, respectively.infected with each of the recombinants were examined
Production by recombinants of the other OV antigensby immunofluorescence with preadsorbed hyperimmune
may be concealed by their comigration with VAC-derivedanti-orf virus antiserum. All VVOV recombinants gave
proteins which form a significant background in this gel.clear specific immunofluorescence. The intensity varied
Serological cross-reactivity between OV and VAC hasbetween recombinants (see Table 2) with recombinants
been reported previously (Webster, 1958). Proteins of96, 245, 247, 285, and 330 giving the strongest fluores-
less than 20 kDa were not resolved in this gel. The re-cence and 82, 97, 215, and 216 the weakest fluorescence.
Cells infected with VVBGAL did not react. maining five members of the library were also screened
TABLE 2
Detection by Immunofluorescence of OV Proteins Expressed from VVOV Recombinants
VVOV Intensity VVOV Intensity VVOV Intensity Virus Intensity
80 /// 212 /// 247 ///// VVBGAL Negative
82 / 213 /// 283 ////
85 /// 215 // 285 ///// OV /////
86 /// 216 // 330 /////
96 ///// 243 ///
97 / 245 /////
Note. Cells infected with the indicated virus were reacted with serum from sheep hyperimmunized with OV. Bound antibody was detected with
anti-sheep IgG conjugated to fluorescein isothiocyanate. The intensity of fluorescence was judged relative to cells infected with OV and the results
expressed on a scale of / to /////.
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FIG. 2. Expression of OV proteins by VVOV recombinants visualized by immunofluorescence. (A) CV-1 cells infected with OV, 1200; (B) CV-1 cells
infected with VVOV recombinant 330, 1200; (C) CV-1 cells infected with VVOV recombinant 96, 1400; (D) CV-1 cells infected with VVOV recombinant
245, 1400.
by immune precipitation and a strong band of 43 kDa nated with either each of the VVOV recombinants or with
VVBGAL. All sites on all four lambs showed typical, dis-was shown to be produced by VVOV80 (results not
shown). The gene encoding this antigen has since been crete VAC-induced lesions which had resolved and de-
tached by 2 weeks postscarification. At 3 weeks of agesequenced and shown to be a homologue of the VAC
37-kDa envelope (Sullivan et al., 1994). all lambs were challenged with OV. The clinical response
to challenge of the four lambs is summarized in Table 3.There was general agreement between the results ob-
tained by immunofluorescence and immune precipita- In both lambs vaccinated with VVBGAL the OV lesions
were typical of a primary OV lesion, progressing fromtion. For example VVOV243, 245, 283, and 285 gave clear
indications of the production of dominant OV antigens erythema through vesicle and pustule formation to scab
over 3 weeks. By contrast, both lambs receiving VVOVwith both techniques, whereas VVOV82 and 97 scored
low with both techniques. recombinants had a much milder and shorter course of
disease with scabs detaching by 13 days after challenge.The above results indicated that all 16 VVOV recombi-
nants expressed OV-specific antigen. We wished to de- The protective effect of prior immunization with the VVOV
recombinants is clearly apparent when the total com-termine if the recombinant library was able to immunize
OV-naive lambs against a challenge with OV. In order to bined clinical scores at 21 days postchallenge are com-
pared: control animals scored 236, whereas animals vac-exclude the possibility of an adventitious infection with
OV which might have compromised the experiment, cinated with the recombinant library scored 52 (Table
3). The mean results for the two sets of animals werelambs were derived by hysterectomy from date-mated
ewes and held in sterile isolators. Lambs were vacci- significantly different from Day 7 postchallenge. Second-
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polymerase complex of different genera of poxviruses
has been exploited previously to identify the fowlpoxvirus
TK gene (Boyle and Coupar, 1986). In an approach similar
to that used here, random fragments of fowlpoxvirus DNA
were recombined into a TK0 VAC and TK/ recombinants
recovered. Although it was not directly demonstrated, it
is reasonable to assume that the promoter sequence of
the fowlpoxvirus TK gene was recognized by VAC. It is
significant that in the studies reported here all recombi-
nants were made by selecting TK0 recombinants from a
TK/ parent. This, in combination with the evidence that
OV promoters are recognized by the VAC transcriptional
machinery, suggests that OV lacks a functional TK gene.
This suggestion is supported by our inability to find a
TK gene in the NZ2 strain of OV by hybridization withFIG. 3. Analysis of proteins immunoprecipitated from the expression
library by anti-OV serum. Infected cell extracts labeled with [35S]- redundant sets of oligonucleotides (unpublished data).
methionine were precipitated with hyperimmune sheep anti-OV serum There remains, however, the possibility that an OV TK
and protein G. Precipitated proteins were detected by autoradiography gene is located in the region not represented in the li-
after separation on a 12.5% SDS–polyacrylamide gel. Lanes 2 to 14
brary (5 kb between VVOV85 and VVOV82).show proteins precipitated from cells infected with VAC, OV, VVOV82,
As the DNA fragments used to construct the libraryVVOV85, VVOV283, VVOV243, VVOV285, VVOV86, VVOV247, VVOV245,
VVOV212, VVOV96, and VVOV97, respectively. Lane 1 contains molecu- were not characterized in terms of their gene content, it
lar weight markers and the bars at the left indicate the bands of 97.4, was recognized that some aberrant transcriptional prod-
69, 46, 30, and 21.5 kDa. Filled squares mark the location of bands ucts might arise from OV sequences at the ends of the
discussed in the text.
inserted fragments. These could result from read-through
into adjacent VAC sequences of an OV open reading
frame interrupted at the 3* end or transcripts might origi-ary OV lesions developed on the lips of both control
nate from adjacent VAC promoters and extend into thelambs, whereas no secondary lesions were observed in
terminal regions of the OV DNA fragment. In the case ofthe two lambs receiving VVOV recombinants.
VVOV80 and those recombinants made with plasmidsEvidence of priming of the immune system by the VVOV
based on pVU77 the only VAC promoter located suchrecombinants was provided by the ELISA results. The two
that it could potentially direct transcription into the OVlambs receiving the VVOV recombinants seroconverted to
sequences is the relatively weak early promoter of theOV within 1 week of challenge and before any antibody
TK gene. Recombinants based on the insertion vector,was detected in the control lambs (Table 4).
pUV1, have a strong late promoter adjacent to one end
of the inserted DNA. The decision to construct an over-DISCUSSION
lapping library was aimed at reducing problems resulting
from such events.The use of VAC to express foreign genes has become
commonplace. In most studies the sequence of the in- Although not considered useful for identifying protec-
tive antigens, the immune precipitation studies demon-serted gene has been determined and the gene placed
so it is transcribed from a strong VAC promoter. In con- strated the utility of the library for locating OV genes
encoding immunodominant antigens. For example, atrast to this, we have constructed an OV expression li-
brary composed of VAC recombinants each carrying an dominant OV antigen was expressed by recombinant
VVOV285 (72 kDa, Fig. 3) but not by the two overlappinguncharacterized multigene fragment of OV DNA and have
relied on the VAC transcriptional complex recognizing recombinants, VVOV86 or VVOV243, suggesting this anti-
gen is encoded by a gene which lies at least partly inthe OV promoters for expression of the genes. The immu-
nofluorescence and immune precipitation studies dem- the 1.5-kb gap between VVOV86 and 243. Similar deduc-
tions are possible for the other antigens detected. Theonstrated that OV antigens are indeed expressed from
these constructs and suggest that a high proportion, per- location and DNA sequence of only one known immuno-
genic gene of a parapoxvirus has been reported (Sullivanhaps all, OV genes are expressed by the library. We have
previously shown that specific OV early (Fleming et al., et al., 1994). The results reported here will assist in the
characterization of other dominant antigens.1992; Vos et al., 1992) and late (Sullivan et al., 1994)
promoters resemble their VAC counterparts and that OV A similar approach has been used to map the location
of genes encoding a limited number of antigens of Afri-early prompters are recognized by VAC. The results pre-
sented here support and extend those observations. can swine fever virus (ASFV) (Hammond and Dixon,
1991). That study used a transient assay in which ASFVCross-recognition between a promoter and the RNA
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TABLE 3
Effect of Immunizing Lambs with VVOV Recombinants on Subsequent Challenge with OV
Controls Vaccinates
Lamb 103 Lamb 104 Lamb 109 Lamb 110
Day E V/P S E V/P S CCS E V/P S E V/P S CCS
1 1 1 2 1 1 2
2 1 1 2 1 1 2
3 2 2 4 2 2 4
4 2 2 4 2 2 4
5 2 2 4 2 2 4
6 2 2 2 2 8 2 2 2 2 8
7 2 2 2 2 8 1 2 1 2 6
8 2 2 2 2 2 2 12 1 2 1 2 6
9 2 2 2 2 2 2 12 2 2 4
10 3 2 2 3 2 2 14 2 2 4
11 3 2 2 3 2 2 14 2 2 4
12 3 2 2 3 2 2 14 2 2 4
13 2 2 3 3 3 3 16
14 2 3 3 3 3 3 17
15 2 3 3 3 3 3 17
16 2 3 3 3 3 3 17
17 2 1 3 3 3 3 15
18 2 3 3 3 3 14
19 2 3 3 3 3 14
20 2 3 3 3 3 14
21 2 3 3 3 3 14
Total
CCS 236 52
Note. Twenty-four hour-old lambs were infected with either all 16 VVOV recombinants (vaccinates) or with VVBGAL (controls). At 3 weeks of age
all lambs were challenged with OV. The resulting lesions were examined daily and scored on a scale of 0 to 3 for erythema (E), vesicle/pustule
formation (V/P), and scab formation (S) (Nettleton et al., 1996). Scores of zero have been omitted from the table. The scores were summed each
day to give a combined clinical score (CCS) for controls and vaccinates. At the end of the experiment all scores for each pair of animals were
combined to give a total CCS.
DNA fragments representing more than 90% of the ge- suggesting that only a minority of ASFV promoters are
recognized by the appropriate VAC elements.nome were introduced into VAC-infected cells and ASFV-
specific proteins detected by immune precipitation. The The animal studies included in this report demonstrate
the validity of the approach we have proposed; they dem-anti-ASFV serum used was able to detect at least 30
proteins from ASFV-infected cells but detected synthesis onstrate that the genes necessary and sufficient for effec-
tive immunization are expressed by the library. The de-of only eight ASFV proteins in the VAC-infected cells,
TABLE 4
Titers of Anti-OV Antibody in Serum Samples Taken from Gnotobiotic Lambs
Age
Lamb No. 1 week 2 weeks 3 weeks 4 weeks 5 weeks 6 weeks
Controls 103 — — — — 1/100 1/400
104 — — — — 1/400 1/12800
Vaccinates 109 — — — 1/400 1/6400 1/6400
110 — — — 1/100 1/400 1/3200
Note. Twenty-four-hour-old lambs were infected with either 16 VVOV recombinants (vaccinates) or with VVBGAL (controls). At 3 weeks of age all
lambs were challenged with OV. Titers of less than 1/100 are shown as a dash.
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production and selection of infectious vaccinia virus recombinantsgree of protection, as measured by the combined clinical
expressing foreign genes. J. Virol. 49, 857–864.scores, provided by the VVOV recombinant library was
Mackett, M., Smith, G. L., and Moss, B. (1985). Vaccinia virus a se-
comparable to that recorded in similar experiments in lectable eukaryotic cloning and expression vector. Proc. Natl. Acad.
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